Search

Author/Creator Voortman, Jens

2. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial. Issue 12 (December 2020)

Authors:
Powles, Thomas; van der Heijden, Michiel S; Castellano, Daniel; Galsky, Matthew D; Loriot, Yohann; Petrylak, Daniel P; Ogawa, Osamu; Park, Se Hoon; Lee, Jae-Lyun; De Giorgi, Ugo; Bögemann, Martin; Bamias, Aristotelis; Eigl, Bernhard J; Gurney, Howard; Mukherjee, Som D; Fradet, Yves; Skoneczna, Iw...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 12(2020)
Page Start:
1574
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Expression of let-7i and miR-192 is associated with resistance to cisplatin-based chemoradiotherapy in patients with larynx and hypopharynx cancer. (October 2020)

Authors:
Poel, Dennis; Rustenburg, François; Sie, Daoud; van Essen, Hendrik F.; Eijk, Paul P.; Bloemena, Elisabeth; Elhorst Benites, Teresita; van den Berg, Madeleine C.; Vergeer, Marije R.; Leemans, René C.; Buffart, Tineke E.; Ylstra, Bauke; Brakenhoff, Ruud H.; Verheul, Henk M.; Voortman, Jens
Journal:
Oral oncology
Issue:
Volume 109(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Genome‐wide aneuploidy detected by mFast‐SeqS in circulating cell‐free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer. Issue 10 (17th March 2022)

Authors:
Mendelaar, Pauline A. J.; Robbrecht, Debbie G. J.; Rijnders, Maud; de Wit, Ronald; de Weerd, Vanja; Deger, Teoman; Westgeest, Hans M.; Aarts, Maureen J. B.; Voortman, Jens; Martens, John W. M.; van der Veldt, Astrid A. M.; Nakauma‐González, José Alberto; Wilting, Saskia M.; Lolkema, Martijn
Journal:
Molecular oncology
Issue:
Volume 16:Issue 10(2022)
Page Start:
2086
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety and Efficacy of Atezolizumab in Understudied Populations with Pretreated Urinary Tract Carcinoma: Subgroup Analyses of the SAUL Study in Real-World Practice. Issue 2 (9th August 2021)

Authors:
Merseburger, Axel S.; Castellano, Daniel; Powles, Thomas; Loriot, Yohann; Retz, Margitta; Voortman, Jens; Huddart, Robert A.; Gedye, Craig; Van Der Heijden, Michiel S.; Gurney, Howard; Ong, Michael; de Ducla, Sabine; Pavlova, Julie; Fear, Simon; Sternberg, Cora N.
Journal:
Journal of urology
Issue:
Volume 206:Issue 2(2021)
Page Start:
240
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Symptom monitoring in cancer and fully automated advice on supportive care: Patients' perspectives on self‐management strategies and the eHealth self‐management application Oncokompas. (2nd August 2021)

Authors:
Schuit, Anouk S.; van Zwieten, Valesca; Holtmaat, Karen; Cuijpers, Pim; Eerenstein, Simone E. J.; Leemans, C. René; Vergeer, Marije R.; Voortman, Jens; Karagozoglu, Hakki; van Weert, Stijn; Korte, Mira; Frambach, Ruud; Fleuren, Margot; Hendrickx, Jan‐Jaap; Verdonck‐de Leeuw, Irma M.
Journal:
European journal of cancer care
Issue:
Volume 30:Number 6(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗